Matches in Nanopublications for { ?s ?p "[ERCC1 and TopoIIalpha are candidate markers in predicting clinical outcome and response to treatment in LD SCLC patients and are worth of further investigation in a prospective study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[ERCC1 and TopoIIalpha are candidate markers in predicting clinical outcome and response to treatment in LD SCLC patients and are worth of further investigation in a prospective study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP381429.RAXamdLLijaPmhQdnH6vNu9z09fIzZ3hdPb84ckreSrE4130_assertion description "[ERCC1 and TopoIIalpha are candidate markers in predicting clinical outcome and response to treatment in LD SCLC patients and are worth of further investigation in a prospective study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381429.RAXamdLLijaPmhQdnH6vNu9z09fIzZ3hdPb84ckreSrE4130_provenance.
- NP674672.RAKWgVNXRc7loGn2U82Eqx800GI3GtHrBo0yE1Zgk-G9U130_assertion description "[ERCC1 and TopoIIalpha are candidate markers in predicting clinical outcome and response to treatment in LD SCLC patients and are worth of further investigation in a prospective study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674672.RAKWgVNXRc7loGn2U82Eqx800GI3GtHrBo0yE1Zgk-G9U130_provenance.